Search

everythinglearnresearchcommunity

for

Search:↓

Using a drug to activate bone marrow stem cells can help the liver regenerate and function better after major surgery in rats.

Using regulatory T cells and Rapamycin together improves chronic graft-versus-host disease treatment outcomes in mice.

The meeting highlighted important advances in stem cell research and its potential for creating new medical treatments.

The muscle damage was caused by T-cell large granular lymphocytic leukemia, not dermatomyositis.

Immune cell-targeting biologics show potential for treating alopecia areata but need better-targeted therapies.

Graft rejection in a hand transplant may trigger hair loss due to autoimmune responses.

Combining mesotherapy with systemic treatments effectively improves alopecia universalis treatment.

Bone marrow cells improved tendon health better than platelet-rich plasma.

CD8+ T cells expand significantly in alopecia areata, suggesting new treatment targets.

The study introduced a new imaging technology to track skin healing and bone marrow cell activity over time.

BMD-1141 effectively regrows hair in alopecia areata with less frequent dosing than current treatments.

Genetically modified umbilical cord blood cells improved skin wound healing in rats.

BI 2536 had limited effectiveness against several advanced cancers and caused significant side effects.

Hair transplant surgery effectively treated a specific type of hair loss and is recommended as a primary treatment option.

Mesenchymal stem cells from laser-assisted liposuction are as effective and safe as those from conventional methods for cell therapy.

Belimumab may cause hair loss in lupus patients.

A Japanese bone marrow transplant patient developed a rare skin cancer possibly linked to long-term use of the medication voriconazole.

Both induced and spontaneous AA lymphocytes can cause alopecia areata in mice.

A patient with leukemia/lymphoma also had multiple autoimmune diseases, suggesting a link between them.

Bone marrow-derived cells contribute to skin tumors, suggesting new treatment targets for non-melanoma skin cancers.

Entospletinib effectively prevents eye and skin GVHD in mice.

A patient regrew hair after a lung transplant using standard post-transplant medication.

Hair transplantation between identical twins can successfully treat severe, nonprogressive hair loss due to follicular aplasia.

Photobiomodulation can help regrow hair in certain types of hair loss.

It's not possible to get unlimited hair for transplants from the same donor area.

Low-dose chemotherapy is safer, more effective, and cost-effective than surgery for treating bone lesions in children.

Non-white organ transplant patients have worse skin cancer outcomes due to later diagnosis and treatment.

New cell sources for bone tissue engineering are promising due to easier harvesting and availability.

A humanized IL-2 fusion protein boosts T regulatory cells and helps control hair loss in Alopecia Areata.